<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02751840</url>
  </required_header>
  <id_info>
    <org_study_id>Tel Hai College RMR-011</org_study_id>
    <nct_id>NCT02751840</nct_id>
  </id_info>
  <brief_title>Effects of Caffeine and Coffee on Resting Metabolic Rate, Comparing Normal Weight Men to Obese Men</brief_title>
  <acronym>RMR</acronym>
  <official_title>Effects of Caffeine and Coffee on Resting Metabolic Rate, Comparing Normal Weight Men to Obese Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel Hai College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel Hai College</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background. The prevalence of obesity has increased in the last two decades. To maintain body&#xD;
      weight energy expenditure (EE) should be equal to energy intake (EI). A low EE predisposes&#xD;
      individuals to weight gain and to obesity that can also results from low resting metabolic&#xD;
      rate (RMR). Caffeine (Caf) is an active food ingredient and is widely consumed globally, and&#xD;
      has an important impact on energy balance. Caf reduces appetite (EI) and increases EE, thus,&#xD;
      Caf has a potential role in body weight reduction. Caf causes higher total daily energy&#xD;
      expenditure (TDEE) in normal weight (NW) people compared to obese (OW). Moreover Caf is&#xD;
      linked to decreased fat oxidation in OW. There are differences between OW and NW in Caf&#xD;
      pharmacokinetics, but no differences reported between NW and OW females in its effects on&#xD;
      RMR. There is a gender difference in the influence of Caf on metabolism. The investigators&#xD;
      are aware of no previous studies which compared the effect of Caf on the RMR of NW and OW&#xD;
      men.&#xD;
&#xD;
      Objectives. 1) To compare the effect of Caf and coffee on resting metabolic rate (RMR) values&#xD;
      in healthy normal-weight (NW) men and overweight (OW) men. 2) To develop Caf intake frequency&#xD;
      questionnaire (in Hebrew)&#xD;
&#xD;
      Hypothesis. RMR values will be higher and respiratory exchange ratio (RER) values will be&#xD;
      lower in NW compared to the values measured in OW men.&#xD;
&#xD;
      Methods. 33 men (16 NW and 17 OW) were reported to the laboratory on 4 separate occasions&#xD;
      (placebo, Caf tablets, coffee and decaffeinated coffee). During the lab sessions they were&#xD;
      undergo complete anthropometric measurements and RMR measured (one of the study conditions)&#xD;
      using indirect calorimetry. Additionally, respiratory exchange ratio (RER) which is&#xD;
      calculated as the ratio between CO2 production (VCO2) and O2 consumption (VO2) (VCO2/VO2),&#xD;
      blood pressure and heart rate (HR) response recorded.&#xD;
&#xD;
      The importance of this study is that the results will contribute to the scientific basis of&#xD;
      weight control and health interventions programs (diet and physical activity) in overweight&#xD;
      men.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods. 16 NW and 17 OW men were reported to the laboratory on 4 separate occasions&#xD;
      (placebo, Caf tablets, coffee and decaffeinated coffee) each separated by 2-7 days. Before&#xD;
      the first meeting they refill caffeine, physical activity and medical questionnaires. The&#xD;
      investigators recruited only men who were healthy non-smokers with no comorbidities and the&#xD;
      daily caffeine consumption was under 400 mg. Before each meeting participants had to comply&#xD;
      guidelines outlined included fasting for 8 hours, avoiding intense physical activity 14 hours&#xD;
      and moderate exercise 2 hours before measurements. The meetings conducted in the morning when&#xD;
      the first session included anthropometric measurements (weight, height and waist&#xD;
      circumference) and body composition measurements using Bioelectrical Impedance Analysis (BIA)&#xD;
      and a digital caliper. Each session began with a measuring resting blood pressure and heart&#xD;
      rate (Polar telemetric systems), after that participants were given randomly placebo or Caf&#xD;
      tablets or coffee or decaffeinated coffee, waiting half an hour and then measuring the RMR&#xD;
      and respiratory exchange ratio (RER), for half an hour using indirect calorimetry (canopy&#xD;
      system). Then again measured blood pressure and heart rate at rest.&#xD;
&#xD;
      The sample size was calculated for 16 participant in each group, according to an expected&#xD;
      change of 3% at RMR values between the groups with the power of 80% and significance of 0.05&#xD;
      . standard deviation (SD).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of resting metabolic expenditure using indirect calorimetry (open flow canopy system)</measure>
    <time_frame>Within two weeks (4 sessions, each 30 minutes)</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Asymptomatic Conditions</condition>
  <arm_group>
    <arm_group_label>Caffeine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Caffeine capsule (200 mg) is taken prior to RMR measurement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (starch) capsule is taken prior to RMR measurement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Coffee</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Black coffee (9 grams) is consumed prior to RMR measurement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Decaffeinated</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Decaffeinated Black coffee (9 grams) is consumed prior to RMR measurement</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Caffeine</intervention_name>
    <description>200 mg of caffeine capsule before RMR measurement</description>
    <arm_group_label>Caffeine</arm_group_label>
    <arm_group_label>Coffee</arm_group_label>
    <arm_group_label>Decaffeinated</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo capsule (starch) before RMR measurement</description>
    <arm_group_label>Caffeine</arm_group_label>
    <arm_group_label>Coffee</arm_group_label>
    <arm_group_label>Decaffeinated</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coffee</intervention_name>
    <description>9 grams of black coffee in boiling water consumed before RMR measurement</description>
    <arm_group_label>Caffeine</arm_group_label>
    <arm_group_label>Coffee</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Decaffeinated</intervention_name>
    <description>9 grams of decaffeinated black coffee in boiling water consumed before RMR measurement</description>
    <arm_group_label>Caffeine</arm_group_label>
    <arm_group_label>Coffee</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        33 Healthy men at the age between 20-50 years. 16 normal weight men and 17 obese men.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Hypertension (above 140/90 mmHg)&#xD;
&#xD;
          2. Taking medications for hypertension&#xD;
&#xD;
          3. Heart, liver or kidney problems, diabetes, respiratory problems, hypo/hyper&#xD;
             thyroidism.&#xD;
&#xD;
          4. Smoking&#xD;
&#xD;
          5. Men who consume caffeine above 400 mg/day&#xD;
&#xD;
          6. Taking medications or dietary supplements that can affect energy expenditure&#xD;
&#xD;
          7. Elite athletes (competitive sport)&#xD;
&#xD;
          8. Night Eating&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Acheson KJ, Zahorska-Markiewicz B, Pittet P, Anantharaman K, Jéquier E. Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr. 1980 May;33(5):989-97.</citation>
    <PMID>7369170</PMID>
  </reference>
  <reference>
    <citation>Adan A, Prat G, Fabbri M, Sànchez-Turet M. Early effects of caffeinated and decaffeinated coffee on subjective state and gender differences. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Oct 1;32(7):1698-703. doi: 10.1016/j.pnpbp.2008.07.005. Epub 2008 Jul 15.</citation>
    <PMID>18675877</PMID>
  </reference>
  <reference>
    <citation>Bracco D, Ferrarra JM, Arnaud MJ, Jéquier E, Schutz Y. Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am J Physiol. 1995 Oct;269(4 Pt 1):E671-8.</citation>
    <PMID>7485480</PMID>
  </reference>
  <reference>
    <citation>Jeukendrup AE, Randell R. Fat burners: nutrition supplements that increase fat metabolism. Obes Rev. 2011 Oct;12(10):841-51. doi: 10.1111/j.1467-789X.2011.00908.x. Review.</citation>
    <PMID>21951331</PMID>
  </reference>
  <reference>
    <citation>Temple JL, Ziegler AM. Gender Differences in Subjective and Physiological Responses to Caffeine and the Role of Steroid Hormones. J Caffeine Res. 2011 Mar;1(1):41-48.</citation>
    <PMID>24761262</PMID>
  </reference>
  <reference>
    <citation>Pohanka M. The perspective of caffeine and caffeine derived compounds in therapy. Bratisl Lek Listy. 2015;116(9):520-30. Review.</citation>
    <PMID>26435014</PMID>
  </reference>
  <verification_date>April 2016</verification_date>
  <study_first_submitted>April 21, 2016</study_first_submitted>
  <study_first_submitted_qc>April 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 26, 2016</study_first_posted>
  <last_update_submitted>April 26, 2016</last_update_submitted>
  <last_update_submitted_qc>April 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asymptomatic Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caffeine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

